Early mortality | Late mortality | |||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Sex (female) | 1.16 (0.82, 1.63) | 0.41 | 0.98 (0.56,1.72) | 0.94 |
Age | 1.04 (1.03, 1.06) | < 0.01 | 1.05 (1.02, 1.07) | < 0.01 |
BMI | 0.95 (0.92, 0.99) | 0.02 | 0.99 (0.94, 1.05) | 0.80 |
Proteinuria | 2.29 (1.59, 3.31) | < 0.01 | 2.12 (1.12, 4.01) | 0.02 |
Diabetes mellitus | 2.33 (1.10, 4.91) | 0.03 | 3.51 (1.32, 9.32) | 0.01 |
Hypertension | 0.56 (0.33, 0.94) | 0.03 | 0.75 (0.37, 1.51) | 0.42 |
WHO stage I (reference) | – | – | – | – |
WHO stage II | 1.52 (0.93, 2.49) | 0.10 | 1.01 (0.48, 2.12) | 0.98 |
WHO stage III | 2.05 (1.28, 3.27) | < 0.01 | 1.82 (0.93, 3.59) | 0.08 |
WHO stage IV | 2.83 (1.67, 4.81) | < 0.01 | 1.49 (0.59,3.81) | 0.40 |
eGFR < 90 mL/min/1.73 m2 | 2.48 (1.56, 3.96) | < 0.01 | 1.29 (0.51, 3.3) | 0.59 |
CD4 count < 50 cells/µL | 1.84 (1.24, 2.72) | < 0.01 | 0.85 (0.37, 1.98) | 0.71 |